The resistance of human immunodeficiency virus type 1 (HIV-1) to antiviral drugs, has prompted a search for alternative therapy methods. This review presents an analysis of the most recent progress in the study of binding among the HIV-1 regulatory/accessory proteins and cell factors, their effects in the cell host and the benefits for the virus. Here, we discuses about how those viral proteins disturb fundamental host cell processes in a very precise way, how the virus uses its proteins to increase the viral replication, to evade the host immune response and to produce disease. RESUMEN La resistencia del virus de la inmunodeficiencia humana tipo 1 (VIH-1) a medicamentos antivirales ha presionado la búsqueda de métodos alternativos de ter...
The development of Acquired Immune Deficiency Syndrome (AIDS) results from infection with the human ...
Tese de doutoramento em Farmácia (Microbiologia), apresentada à Universidade de Lisboa através da Fa...
AbstractCurrent treatment of HIV/AIDS consists of a combination of three to five agents targeting di...
La resistencia del virus de la inmunodeficiencia humana tipo 1 (VIH-1) a medicamentos antivirales h...
Resumen El Virus de la Inmunodeficiencia Humana tipo 1 (VIH-1) es un retrovirus complejo que codifi...
Productive HIV infection requires completion of all the steps of the replication cycle, the success ...
SummaryOne of the features of primate immunodeficiency viruses (HIVs and SIVs) that distinguishes th...
The human immunodeficiency virus type 1 (HIV-1) Vpr protein is an attractive target for antiretrovir...
Tese de doutoramento, Farmácia (Microbiologia), Universidade de Lisboa, Faculdade de Farmácia, 2010....
Resumen El Virus de la Inmunodeficiencia Humana (VIH), como la mayoría de los virus envueltos, toma...
Tesis Doctoral inédita leída en la Universidad Autónoma de Madrid. Facultad de Ciencias, Departament...
El VIH és un patogen intracel·lular obligat i per tant està totalment subjecte als recursos intracel...
Tese de mestrado, Biologia (Biologia Molecular Humana), 2009, Universidade de Lisboa, Faculdade de C...
The Human Immunodeficiency Virus (HIV) genome encodes three major structural proteins common to all ...
El HIV/SIDA afecta a más de 40 millones de personas en todo el mundo. Los altos costos de los antire...
The development of Acquired Immune Deficiency Syndrome (AIDS) results from infection with the human ...
Tese de doutoramento em Farmácia (Microbiologia), apresentada à Universidade de Lisboa através da Fa...
AbstractCurrent treatment of HIV/AIDS consists of a combination of three to five agents targeting di...
La resistencia del virus de la inmunodeficiencia humana tipo 1 (VIH-1) a medicamentos antivirales h...
Resumen El Virus de la Inmunodeficiencia Humana tipo 1 (VIH-1) es un retrovirus complejo que codifi...
Productive HIV infection requires completion of all the steps of the replication cycle, the success ...
SummaryOne of the features of primate immunodeficiency viruses (HIVs and SIVs) that distinguishes th...
The human immunodeficiency virus type 1 (HIV-1) Vpr protein is an attractive target for antiretrovir...
Tese de doutoramento, Farmácia (Microbiologia), Universidade de Lisboa, Faculdade de Farmácia, 2010....
Resumen El Virus de la Inmunodeficiencia Humana (VIH), como la mayoría de los virus envueltos, toma...
Tesis Doctoral inédita leída en la Universidad Autónoma de Madrid. Facultad de Ciencias, Departament...
El VIH és un patogen intracel·lular obligat i per tant està totalment subjecte als recursos intracel...
Tese de mestrado, Biologia (Biologia Molecular Humana), 2009, Universidade de Lisboa, Faculdade de C...
The Human Immunodeficiency Virus (HIV) genome encodes three major structural proteins common to all ...
El HIV/SIDA afecta a más de 40 millones de personas en todo el mundo. Los altos costos de los antire...
The development of Acquired Immune Deficiency Syndrome (AIDS) results from infection with the human ...
Tese de doutoramento em Farmácia (Microbiologia), apresentada à Universidade de Lisboa através da Fa...
AbstractCurrent treatment of HIV/AIDS consists of a combination of three to five agents targeting di...